Feb 24 (Reuters) - CSL Ltd (CSL) :
- SEQIRUS RECEIVES FDA APPROVAL FOR FLUAD® QUADRIVALENT (INFLUENZA VACCINE, ADJUVANTED) FOR ADULTS 65 YEARS AND OLDER
News: CSL Seqirus Receives FDA Approval For FLUAD® QUADRIVALENT
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$300.89 |
Change
0.120(0.04%) |
Mkt cap ! $146.5B | |||
| Open | High | Low | Value | Volume |
| $301.69 | $304.00 | $299.62 | $83.01M | 274.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25 | $300.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $300.89 | 88 | 6 |
View Market Depth
| Last trade - 12.06pm 15/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |